Evidence map›Paper›PMID 21255362›Full record

ReviewMicrobial biotechnology2010

Comparative genome-wide analysis of small RNAs of major Gram-positive pathogens: from identification to application.

Mobarak A Mraheil, André Billion, Carsten Kuenne, Jordan Pischimarov, Bernd Kreikemeyer, Susanne Engelmann, Axel Hartke, Jean-Christophe Giard, Maja Rupnik, Sonja Vorwerk and 8 more

Abstract readReview
In one paragraph

Review in Microbial biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. The Small RNA RyhB Homologs fromMicroorganisms · 2021
    Article
  4. The Regulatory RNAFrontiers in microbiology · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. In silico prediction and qPCR validation of novel sRNAs inJournal, genetic engineering & biotechnology · 2016
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification and Role of Regulatory Non-Coding RNAs inInternational journal of molecular sciences · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mobarak A MraheilInstitute of Medical Microbiology, Justus-Liebig-University, Frankfurter Strasse 107, 35392 Giessen, Germany.
André Billion
Carsten Kuenne
Jordan Pischimarov
Bernd Kreikemeyer
Susanne Engelmann
Axel Hartke
Jean-Christophe Giard
Maja Rupnik
Sonja Vorwerk
Markus Beier
Julia Retey
Thomas Hartsch
Anette Jacob
Franz Cemič
Jürgen Hemberger
Trinad Chakraborty
Torsten Hain

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the recent years, the number of drug- and multi-drug-resistant microbial strains has increased rapidly. Therefore, the need to identify innovative approaches for development of novel anti-infectives and new therapeutic targets is of high priority in global health care. The detection of small RNAs (sRNAs) in bacteria has attracted considerable attention as an emerging class of new gene expression regulators. Several experimental technologies to predict sRNA have been established for the Gram-negative model organism Escherichia coli. In many respects, sRNA screens in this model system have set a blueprint for the global and functional identification of sRNAs for Gram-positive microbes, but the functional role of sRNAs in colonization and pathogenicity for Listeria monocytogenes, Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis and Clostridium difficile is almost completely unknown. Here, we report the current knowledge about the sRNAs of these socioeconomically relevant Gram-positive pathogens, overview the state-of-the-art high-throughput sRNA screening methods and summarize bioinformatics approaches for genome-wide sRNA identification and target prediction. Finally, we discuss the use of modified peptide nucleic acids (PNAs) as a novel tool to inactivate potential sRNA and their applications in rapid and specific detection of pathogenic bacteria.

Indexed as

Gene Expression Regulation, BacterialAnti-Bacterial AgentsBacteriological TechniquesBiological ProductsGram-Positive BacteriaGram-Positive Bacterial InfectionsHumansRNA, AntisenseRNA, Small InterferingAnti-Bacterial AgentsBiological ProductsRNA, AntisenseRNA, Small Interfering

Identifiers

PMID21255362
PMCPMC3815340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.